You are here

immunotherapy

Roche's star immunotherapy posts positive results in bladder cancer

Fierce Biotech

Sat, 01/9/16 - 10:36 am

The Path Is Clear for a New Immunotherapy Entrant

Motley Fool

Tue, 12/1/15 - 02:16 pm

How Roche is applying immunotherapy techniques to fight bacterial infections

BioPharma Dive

Fri, 11/6/15 - 10:42 am

antibody–antibiotic conjugate

Not just cancer: Seattle biotechs, researchers explore immunotherapy for other diseases

Bizjournals.com

Fri, 08/28/15 - 07:59 am

Juno Therapeutics

Ichor, J&J to collaborate in $85M hep B immunotherapy deal

BioPharma Dive

Wed, 04/15/15 - 08:51 am

TapImmune's CEO Says Company Is Preparing "A Very Deep Pipeline in Multiple Indications" for Phase II Trials

Yahoo

Tue, 02/10/15 - 10:04 am

Lilly to Pair With Merck, Bristol on Cancer Drug Trials

WSJ Online

Tue, 01/13/15 - 09:54 am

Bristol-Myers Squibb

clinical trials

2015 an "important year" for Pfizer's IO pipeline, analysts say

Medical Marketing and Media

Fri, 11/14/14 - 10:59 am

Merck immunotherapy drug shows promise in bladder cancer

Yahoo/Reuters

Mon, 09/29/14 - 07:52 am

Amgen One Step Closer To Immunotherapy Market

Bidness Etc.

Tue, 09/23/14 - 07:33 am

acute lymphoblastic leukemia

Pharma’s Huge Bet on Immunotherapies

Motley Fool

Wed, 06/25/14 - 07:35 am

anti-PD-1 immunotherapy

Bristol-Myers Squibb

Incyte's 'IDO' Cancer Immunotherapy Causes Investor Scrum at ASCO '14

TheStreet.com

Mon, 06/2/14 - 06:09 pm

U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors

Yahoo/Reuters

Mon, 06/2/14 - 09:42 am

Bristol-Myers Squibb

Bristol-Myers racing to the FDA with immunotherapy star nivolumab

Fierce Biotech

Tue, 04/29/14 - 10:05 am

Bristol-Myers Squibb

Who's going to win pharma's immunotherapy gold rush?

Fierce Biotech

Tue, 03/25/14 - 08:08 am

Bristol-Myers Squibb

anti-PD-1 immunotherapy

3 Growing Immunotherapy Companies: Celldex, Merck, OncoSec

Wall St Cheat Sheet

Mon, 02/10/14 - 11:28 am

Ablynx agrees Merck cancer deal worth up to 1.7 billion euros

Yahoo/Reuters

Mon, 02/3/14 - 08:50 am

6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014

Seeking Alpha

Fri, 01/31/14 - 08:14 am

Bristol-Myers Squibb

Advaxis And Inovio Race For First Cervical Cancer Immunotherapy

Seeking Alpha

Thu, 01/23/14 - 09:48 am

cervical cancer

Amazon's Jeff Bezos bets some of his personal cash on Juno's immunotherapy tech

Fierce Biotech

Tue, 01/14/14 - 10:00 am

Juno Therapeutics

Pages